[ad_1]
There is debate over confidence about the vaccine, which was developed by AstraZeneca and the University of Oxford and promoted as “cheaper than a cup of coffee”.
AstraZeneca sparked controversy, admitting that there was a significant error in the vaccine dosage received by some participants, as the New York Times reported preliminary results that were declared 90% effective.
Many scientists and industry experts pointed out that AstraZeneca’s initial lack of explanation of the data, many errors such as the way the vaccine was administered, undermined their confidence in the reliability of the results.
Notably, US officials pointed out that the results, announced as a 90% effect, do not reflect seniors’ data and that the results are unclear.
Authorities said this makes it less likely that US or other country approval authorities will quickly grant emergency use of the vaccine to AstraZeneca – University of Oxford, and this was a glitch.
class = “cf”>
AstraZeneca’s director of research and development, Menelas Pangalos, argued in an interview Wednesday that the company handled the testing and public disclosures. He said the mistake in the dosage was made by an employee, was immediately notified when detected, and signed a plan to continue testing the vaccine at different doses.
However, Natalie Dean, a biostatistician at the University of Florida, said they “scored poorly in terms of transparency and rigor in the results reported.”
The vaccine developed by AstraZeneca and the University of Oxford was announced with the slogan “Get a vaccine”, emphasizing that it is cheaper than a cup of coffee.
THIS VIDEO MAY BE INTERESTED
.
[ad_2]
Source link
